As many as 1 million Americans live with Parkinson’s disease and about 60,000 more are diagnosed each year. In Louisiana, Parkinson’s affects more than 65,000 individuals — one of the higher incidence rates in the nation.

According to the American Journal of Managed Care, the annual economic impact of Parkinson’s disease in the U.S. is roughly $10.8 billion, including both direct medical expenses and indirect costs such as lost income, disability payments and medical costs.

To underscore the importance of translating research on Parkinson’s disease into improved treatments and an eventual cure, Pennington Biomedical will host the third annual Parkinson’s Conference on Saturday, July 19.

“Once again we’ve assembled an outstanding program with experts on topics from the basic mechanisms of the disease and treatment strategies, to family and societal impacts – and we’ve allowed ample time for audience questions and discussion,” said Dr. Donald Ingram, one of the event organizers and the lead researcher in the Nutritional Neuroscience and Aging Laboratory at Pennington Biomedical.

The conference also will feature several exhibitors offering information pertinent to patients with Parkinson’s disease and their families.

The conference can accommodate only 400, so advanced registration is encouraged. Online registration will close once capacity attendance has been reached. Walk-in registrations on the day of the event cannot be accepted. The conference will be held at Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, in the C.B. Pennington Jr. Building. For more information, visit

Editor’s note: This story was changed on June 16, 2014, to add the month and date of the conference.